Celltrion: Celltrion Inc.’s autoimmune disease treatment, SteQeyma, has been launched in five major European nations, the Korean company said Thursday. SteQeyma, an ustekinumab biosimilar treatment

Seoul: South Korea’s domestic market for automobiles posted its weakest performance in over a decade last year on reduced demand among self-employed individuals and young

Seoul: South Korean stocks opened weaker Thursday as investors took profit following strong gains in the previous session despite an overnight rally on Wall Street.

Seoul: Opposition leader Lee Jae-myung said Thursday that South Korea could be sidelined if stalled talks between the United States and North Korea resume under

Seoul: The South Korean economy posted weaker-than-expected growth last year amid slowing export growth, sagging domestic demand, and a political crisis, central bank data showed

Seoul: South Koreans’ consumption of rice continued its downward trend, reaching an all-time low in 2024, primarily due to changes in their diet and eating